Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,668.20
0.55%
Copper
4.16
0.06%
Oil
68.95
(0.86%)
Bitcoin
96,829.25
2.63%
FTSE 100
8,101.66
0.21%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.18%
Hang Seng
19,601.11
(0.23%)

Neurotech International Ltd

NTI

ASX

Neurotech International Limited (NTI) operates as a clinical-stage biopharmaceutical development company with a primary focus on paediatric neurological disorders. Its core mission involves the advancement of research and the development of innovative therapies aimed at enhancing the quality of life for children affected by these conditions. NTI is committed to both the development and commercialisation of novel neurological treatments, leveraging its expertise to provide compassionate care and meaningful advancements in paediatric neurology.

Latest Posts

Line Chart with Gradient
Price
$0.067
0.001 (1.52%)
At Close 20/11 (AEST)
Related Companies
HERAMED LIMITED
$HMD
VISIONFLEX GROUP LIMITED
$VFX
AUSTRALIAN CLINICAL LABS LIMITED
$ACL
TRIVARX LTD
$TRI
IMEXHS LIMITED
$IME

Leave a Comment on NTI


Comments for NTI

    Latest Posts

    neurotech-international-asx-nti-to-pursue-targeted-global-partnering-strategy-and-registration-directed-initiatives-in-australia-nti
    Health Care $NTI

    Neurotech International (ASX: $NTI) to pursue targeted global partnering strategy and registration-directed initiatives in australia

    Company to secure strategic partnerships for NTI164 and pursue multiple registrations in Australia

    August 12, 2024
    neurotech-international-asx-nti-reports-positive-clinical-trial-results-in-paediatric-neurological-disorders-nti
    Health Care $NTI

    Neurotech International (ASX: $NTI) reports positive clinical trial results in paediatric neurological disorders

    Clinical trial data shows significant improvements in ASD and Rett Syndrome patients

    July 25, 2024
    neurotech-international-asx-nti-demonstrates-significant-improvements-in-asd-patients-nti
    Health Care $NTI

    Neurotech International (ASX: $NTI) demonstrates significant improvements in ASD patients

    Phase II/III clinical trial shows 56% improvement in ASD symptoms after 12 weeks of NTI164 therapy

    July 10, 2024
    neurotech-international-asx-nti-reports-clinical-improvement-in-pandas-pans-patients-nti
    Health Care $NTI

    Neurotech International (ASX: $NTI) reports clinical improvement in PANDAS/PANS patients

    NTI164 treatment shows significant improvements in anxiety and depression in children with PANDAS/PANS

    June 6, 2024
    neurotech-international-asx-nti-reports-clinical-benefits-in-rett-syndrome-trial-nti
    Health Care $NTI

    Neurotech International (ASX: $NTI) reports clinical benefits in rett syndrome trial

    NTI164 shows significant improvement in Rett Syndrome patients after 12-week trial period

    May 6, 2024
    neurotech-international-asx-nti-extends-clinical-trials-in-paediatric-neurological-disorders-nti
    Health Care $NTI

    Neurotech International (ASX: $NTI) extends clinical trials in paediatric neurological disorders

    Positive results from ASD and Rett Syndrome trials, $10.0 million capital raise

    April 24, 2024
    neurotech-international-asx-nti-advances-pediatric-neurological-therapies-nti
    Health Care $NTI
    Neurotech International (ASX: $NTI) advances pediatric neurological therapiesFocuses on NTI164 for Autism Spectrum Disorder and Rett Syndrome while seeking strategic partnerships

    October 23, 2024

    neurotech-international-asx-nti-receives-fda-response-on-orphan-drug-request-nti
    Health Care $NTI

    Neurotech International (ASX: $NTI) receives FDA response on orphan drug request

    US FDA declines orphan drug status for NTI164 in PANDAS/PANS, 12-month abeyance granted for response

    October 4, 2024

    NTI

    $NTI

    Neurotech International (ASX: $NTI) to pursue targeted global partnering strategy and registration-directed initiatives in australia

    Company to secure strategic partnerships for NTI164 and pursue multiple registrations in Australia

    NTI

    $NTI

    Neurotech International (ASX: $NTI) reports positive clinical trial results in paediatric neurological disorders

    Clinical trial data shows significant improvements in ASD and Rett Syndrome patients

    NTI

    $NTI

    Neurotech International (ASX: $NTI) demonstrates significant improvements in ASD patients

    Phase II/III clinical trial shows 56% improvement in ASD symptoms after 12 weeks of NTI164 therapy

    NTI

    $NTI

    Neurotech International (ASX: $NTI) reports clinical improvement in PANDAS/PANS patients

    NTI164 treatment shows significant improvements in anxiety and depression in children with PANDAS/PANS

    NTI

    $NTI

    Neurotech International (ASX: $NTI) reports clinical benefits in rett syndrome trial

    NTI164 shows significant improvement in Rett Syndrome patients after 12-week trial period

    NTI

    $NTI

    Neurotech International (ASX: $NTI) extends clinical trials in paediatric neurological disorders

    Positive results from ASD and Rett Syndrome trials, $10.0 million capital raise

    Related Companies
    SOMNOMED LIMITED
    $SOM
    USCOM LIMITED
    $UCM
    SINGULAR HEALTH GROUP LTD
    $SHG
    NOVA EYE MEDICAL LIMITED
    $EYE
    OCEANIA HEALTHCARE LIMITED
    $OCA

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions